Treatment success for diabetic kidney disease
Clinical trial findings inThe New England Journal of Medicine report that canagliflozin can reduce the risk of kidney and cardiac failure in patients with diabetes.iNews
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Canagliflozin | Clinical Trials | Diabetes | Endocrinology | Invokana | Urology & Nephrology